Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.

Lewis RE, Wurster S, Beyda ND, Albert ND, Kontoyiannis DP.

Diagn Microbiol Infect Dis. 2019 Nov;95(3):114861. doi: 10.1016/j.diagmicrobio.2019.06.013. Epub 2019 Jul 5.

PMID:
31427139
2.

Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.

Wurster S, Bandi A, Beyda ND, Albert ND, Raman NM, Raad II, Kontoyiannis DP.

J Antimicrob Chemother. 2019 Jul 1;74(7):1904-1910. doi: 10.1093/jac/dkz100.

PMID:
31225606
3.

Adjuvant β-Lactam Therapy Combined with Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia: Does β-Lactam Class Matter?

Dilworth TJ, Casapao AM, Ibrahim OM, Jacobs DM, Bowers DR, Beyda ND, Mercier RC.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e02211-18. doi: 10.1128/AAC.02211-18. Print 2019 Mar.

4.

In Vitro Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals.

Beyda ND, Amadio J, Rodriguez JR, Malinowski K, Garey KW, Wanger A, Ostrosky-Zeichner L.

J Clin Microbiol. 2018 Jul 26;56(8). pii: e00471-18. doi: 10.1128/JCM.00471-18. Print 2018 Aug.

5.

Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA.

Sofjan AK, Musgrove RJ, Beyda ND, Russo HP, Lasco TM, Yau R, Restrepo A, Garey KW.

J Glob Antimicrob Resist. 2018 Dec;15:41-47. doi: 10.1016/j.jgar.2018.05.015. Epub 2018 May 26.

PMID:
29842975
6.

Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy.

Sofjan AK, Mitchell A, Shah DN, Nguyen T, Sim M, Trojcak A, Beyda ND, Garey KW.

J Glob Antimicrob Resist. 2018 Sep;14:58-64. doi: 10.1016/j.jgar.2018.02.013. Epub 2018 Feb 24.

7.

Overtreatment of Asymptomatic Candiduria among Hospitalized Patients: a Multi-institutional Study.

Jacobs DM, Dilworth TJ, Beyda ND, Casapao AM, Bowers DR.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01464-17. doi: 10.1128/AAC.01464-17. Print 2018 Jan.

8.

Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.

Casapao AM, Jacobs DM, Bowers DR, Beyda ND, Dilworth TJ; REACH-ID Study Group.

Pharmacotherapy. 2017 Nov;37(11):1347-1356. doi: 10.1002/phar.2034. Epub 2017 Nov 2.

PMID:
28949410
9.

Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.

Beyda ND, Liao G, Endres BT, Lewis RE, Garey KW.

Antimicrob Agents Chemother. 2015 Sep;59(9):5405-12. doi: 10.1128/AAC.00624-15. Epub 2015 Jun 22.

10.

Echinocandin use in hospitalized patients: a multi-institutional study.

Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL.

Am J Med Sci. 2015 Apr;349(4):316-20. doi: 10.1097/MAJ.0000000000000412.

PMID:
25607510
11.

Host factors and clinical outcomes of Candida colonization in critically ill patients.

Jacobs DM, Beyda ND, Asuphon O, Alam MJ, Garey KW.

Mycopathologia. 2015 Feb;179(1-2):87-93. doi: 10.1007/s11046-014-9809-6. Epub 2014 Aug 31.

PMID:
25173925
12.

FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.

Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW.

Clin Infect Dis. 2014 Sep 15;59(6):819-25. doi: 10.1093/cid/ciu407. Epub 2014 May 30.

PMID:
24879785
13.

Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics.

Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW.

Ann Pharmacother. 2014 Jun;48(6):683-90. doi: 10.1177/1060028014529928. Epub 2014 Mar 31.

PMID:
24687545
14.

Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples.

Beyda ND, Alam MJ, Garey KW.

Diagn Microbiol Infect Dis. 2013 Dec;77(4):324-6. doi: 10.1016/j.diagmicrobio.2013.07.007. Epub 2013 Oct 14.

PMID:
24135411
15.

Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.

Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW.

J Hosp Infect. 2013 Sep;85(1):28-32. doi: 10.1016/j.jhin.2013.04.017. Epub 2013 Jul 5.

PMID:
23834988
16.

Treatment of Candida famata bloodstream infections: case series and review of the literature.

Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW.

J Antimicrob Chemother. 2013 Feb;68(2):438-43. doi: 10.1093/jac/dks388. Epub 2012 Oct 19. Review.

PMID:
23085777
17.

Significant publications on infectious diseases pharmacotherapy in 2011.

Tran TT, Beyda ND, Biehle LR, Cottreau JM, Echevarria K, Musick WL, Perez KK, Schilling AN; Houston Infectious Diseases Network.

Am J Health Syst Pharm. 2012 Oct 1;69(19):1671-81.

PMID:
22997121
18.

Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.

Beyda ND, Lewis RE, Garey KW.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):1086-96. doi: 10.1345/aph.1R020. Epub 2012 Jul 17. Review.

PMID:
22811350

Supplemental Content

Loading ...
Support Center